Distribution characteristics of circulating B cell subpopulations in patients with chronic kidney disease

Xuya Chen1, Haoyang Guo1, Danxia Jin1

  • 1Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, 60 West Wuning Road, Dongyang, 322100, Zhejiang, China.

Scientific Reports
|November 27, 2023
PubMed

Insights

Chronic kidney disease (CKD) alters circulating B cell subpopulations, with advanced stages showing decreased transitional and CD5+ B cells. Haemodialysis effects on these immune cells in end-stage renal disease require further investigation.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Chronic kidney disease (CKD) is associated with immune dysregulation.
  • Understanding B cell dynamics in CKD is crucial for managing immune homeostasis.
  • The impact of renal function decline on B cell subpopulations remains incompletely understood.

Purpose of the Study:

  • To compare B cell subpopulations across different CKD stages.
  • To investigate the effects of haemodialysis (HD) on B cell profiles in end-stage renal disease (ESRD).
  • To evaluate the relationship between renal function and immune balance in CKD patients.

Main Methods:

  • Flow cytometry analysis of circulating B cell subpopulations.
  • Inclusion of 197 CKD patients (stages I-V, including HD patients) and 77 healthy controls.
  • Comparison of B cell distribution between CKD stages, healthy controls, and pre/post-HD.

Main Results:

  • CKD stage V patients exhibited decreased transitional B cells and CD5+ B cells, alongside increased double-negative (DN) B cells compared to controls.
  • Advanced CKD stages showed a significant reduction in the absolute counts of various B cell subpopulations.
  • B cell subpopulation distribution was significantly altered with CKD progression; HD effects on DN and CD5+ B cells were inconsistent.

Conclusions:

  • Circulating B cell subpopulations are significantly altered in CKD and associated with disease progression.
  • Immune homeostasis is disrupted in CKD, with specific changes in B cell subsets.
  • Further research into HD's impact on B cell profiles is warranted for clinical implications.